{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:33:49Z","timestamp":1789760029864,"version":"4.0.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12916-017-0922-5","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T07:49:15Z","timestamp":1502437755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["What makes gouty inflammation so variable?"],"prefix":"10.1186","volume":"15","author":[{"given":"Robert","family":"Terkeltaub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,18]]},"reference":[{"issue":"10","key":"922_CR1","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63(10):3136\u201341.","journal-title":"Arthritis Rheum"},{"key":"922_CR2","first-page":"971","volume":"9","author":"PP Khanna","year":"2015","unstructured":"Khanna PP, Shiozawa A, Walker V, Bancroft T, Essoi B, Akhras KS, Khanna D. Health-related quality of life and treatment satisfaction in patients with gout: results from a cross-sectional study in a managed care setting. Patient Prefer Adherence. 2015;9:971\u201381.","journal-title":"Patient Prefer Adherence."},{"issue":"6","key":"922_CR3","doi-asserted-by":"crossref","first-page":"e007214","DOI":"10.1136\/bmjopen-2014-007214","volume":"5","author":"R Jackson","year":"2015","unstructured":"Jackson R, Shiozawa A, Buysman EK, Altan A, Korrer S, Choi H. Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis. BMJ Open. 2015;5(6):e007214.","journal-title":"BMJ Open"},{"issue":"7","key":"922_CR4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med. 2012;125(7):679\u201387.e1.","journal-title":"Am J Med"},{"issue":"2","key":"922_CR5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.amjmed.2010.09.012","volume":"124","author":"RT Keenan","year":"2011","unstructured":"Keenan RT, O'Brien WR, Lee KH, Crittenden DB, Fisher MC, Goldfarb DS, Krasnokutsky S, Oh C, Pillinger MH. Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med. 2011;124(2):155\u201363.","journal-title":"Am J Med"},{"issue":"1","key":"922_CR6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/art.39799","volume":"69","author":"N Dalbeth","year":"2017","unstructured":"Dalbeth N, Choi HK, Terkeltaub R. Review: Gout: a roadmap to approaches for improving global outcomes. Arthritis Rheumatol. 2017;69(1):22\u201334.","journal-title":"Arthritis Rheumatol"},{"issue":"21","key":"922_CR7","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/jama.2016.3517","volume":"315","author":"SY Lim","year":"2016","unstructured":"Lim SY, Lu N, Oza A, Fisher M, Rai SK, Menendez ME, Choi HK. Trends in gout and rheumatoid arthritis hospitalizations in the United States, 1993-2011. JAMA. 2016;315(21):2345\u20137.","journal-title":"JAMA"},{"key":"922_CR8","first-page":"59","volume-title":"Gout and Other Crystal Deposition Arthropathies","author":"R Liu-Bryan","year":"2011","unstructured":"Liu-Bryan R, Terkeltaub R. Tophus Biology and Pathogenesis of Monosodium Urate Crystal-Induced Inflammation. In: Terkeltaub R, editor. Gout and Other Crystal Deposition Arthropathies. Philadelphia, PA: Elsevier; 2011. p. 59\u201371."},{"issue":"Suppl1","key":"922_CR9","volume":"1","author":"G Schett","year":"2015","unstructured":"Schett G, Schauer C, Hoffmann M, Herrmann M. Why does the gout attack stop? A roadmap for the immune pathogenesis of gout. RMD Open. 2015;1(Suppl1), e000046.","journal-title":"RMD Open"},{"issue":"2","key":"922_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/BOR.0000000000000366","volume":"29","author":"MC Cleophas","year":"2017","unstructured":"Cleophas MC, Cri\u015fan TO, Joosten LA. Factors modulating the inflammatory response in acute gouty arthritis. Curr Opin Rheumatol. 2017;29(2):163\u201370.","journal-title":"Curr Opin Rheumatol"},{"issue":"5963","key":"922_CR11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.1184003","volume":"327","author":"K Schroder","year":"2010","unstructured":"Schroder K, Zhou R, Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger? Science. 2010;327(5963):296\u2013300.","journal-title":"Science"},{"issue":"2","key":"922_CR12","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/art.33355","volume":"64","author":"FA Amaral","year":"2012","unstructured":"Amaral FA, Costa VV, Tavares LD, Sachs D, Coelho FM, Fagundes CT, Soriani FM, et al. NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout. Arthritis Rheum. 2012;64(2):474\u201384.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"922_CR13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/eji.201545798","volume":"46","author":"FA Amaral","year":"2016","unstructured":"Amaral FA, Bastos LF, Oliveira TH, Dias AC, Oliveira VL, Tavares LD, Costa VV, et al. Transmembrane TNF-\u03b1 is sufficient for articular inflammation and hypernociception in a mouse model of gout. Eur J Immunol. 2016;46(1):204\u201311.","journal-title":"Eur J Immunol"},{"issue":"6","key":"922_CR14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/acr.23082","volume":"69","author":"S Stewart","year":"2017","unstructured":"Stewart S, Dalbeth N, Vandal AC, Allen B, Miranda R, Rome K. Ultrasound features of the first metatarsophalangeal joint in gout and asymptomatic hyperuricemia: comparison with normouricemic individuals. Arthritis Care Res (Hoboken). 2017;69(6):875\u201383.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"922_CR15","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/annrheumdis-2014-206397","volume":"74","author":"N Dalbeth","year":"2015","unstructured":"Dalbeth N, House ME, Aati O, Tan P, Franklin C, Horne A, Gamble GD, et al. Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study. Ann Rheum Dis. 2015;74(5):908\u201311.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"922_CR16","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000075","volume":"1","author":"EG Araujo","year":"2015","unstructured":"Araujo EG, Bayat S, Petsch C, Englbrecht M, Faustini F, Kleyer A, Hueber AJ, et al. Tophus resolution with pegloticase: a prospective dual-energy CT study. RMD Open. 2015;1(1), e000075.","journal-title":"RMD Open"},{"issue":"5","key":"922_CR17","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2214\/AJR.15.15356","volume":"206","author":"A Carr","year":"2016","unstructured":"Carr A, Doyle AJ, Dalbeth N, Aati O, McQueen FM. Dual-energy CT of urate deposits in costal cartilage and intervertebral disks of patients with tophaceous gout and age-matched controls. AJR Am J Roentgenol. 2016;206(5):1063\u20137.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"922_CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13075-017-1286-0","volume":"19","author":"J Zhu","year":"2017","unstructured":"Zhu J, Li A, Jia E, Zhou Y, Xu J, Chen S, Huang Y, et al. Monosodium urate crystal deposition associated with the progress of radiographic grade at the sacroiliac joint in axial SpA: a dual-energy CT study. Arthritis Res Ther. 2017;19(1):83.","journal-title":"Arthritis Res Ther"},{"key":"922_CR19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.semarthrit.2015.11.014","volume":"45","author":"C Petsch","year":"2016","unstructured":"Petsch C, Araujo EG, Englbrecht M, Bayat S, Cavallaro A, Hueber AJ, Lell M, et al. Prevalence of monosodium urate deposits in a population of rheumatoid arthritis patients with hyperuricemia. Semin Arthritis Rheum. 2016;45:663\u20138.","journal-title":"Semin Arthritis Rheum"},{"key":"922_CR20","doi-asserted-by":"crossref","first-page":"38229","DOI":"10.1038\/srep38229","volume":"6","author":"E Pieterse","year":"2016","unstructured":"Pieterse E, Jeremic I, Czegley C, Weidner D, Biermann MH, Veissi S, Mauer\u00f6der C, et al. Blood-borne phagocytes internalize urate microaggregates and prevent intravascular NETosis by urate crystals. Sci Rep. 2016;6:38229.","journal-title":"Sci Rep"},{"issue":"7","key":"922_CR21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","volume":"21","author":"H Guo","year":"2015","unstructured":"Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21(7):677\u201387.","journal-title":"Nat Med"},{"issue":"6","key":"922_CR22","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/art.39102","volume":"67","author":"A Haslberger","year":"2015","unstructured":"Haslberger A, Terkeltaub R. Editorial: can GPR43 sensing of short-chain fatty acids unchain inflammasome-driven arthritis? Arthritis Rheumatol. 2015;67(6):1419\u201323.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"922_CR23","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/art.27667","volume":"62","author":"LA Joosten","year":"2010","unstructured":"Joosten LA, Netea MG, Mylona E, Koenders MI, Malireddi RK, Oosting M, Stienstra R, et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1\u03b2 production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 2010;62(11):3237\u201348.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"922_CR24","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/annrheumdis-2015-207338","volume":"75","author":"A Cumpelik","year":"2016","unstructured":"Cumpelik A, Ankli B, Zecher D, Schifferli JA. Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasome. Ann Rheum Dis. 2016;75(6):1236\u201345.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"922_CR25","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/art.38730","volume":"66","author":"OM Shaw","year":"2014","unstructured":"Shaw OM, Steiger S, Liu X, Hamilton JA, Harper JL. Brief report: Granulocyte-macrophage colony-stimulating factor drives monosodium urate monohydrate crystal-induced inflammatory macrophage differentiation and NLRP3 inflammasome up-regulation in an in vivo mouse model. Arthritis Rheumatol. 2014;66(9):2423\u20138.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"922_CR26","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","volume":"18","author":"EL Goldberg","year":"2017","unstructured":"Goldberg EL, Asher JL, Molony RD, Shaw AC, Zeiss CJ, Wang C, Morozova-Roche LA, et al. \u03b2-Hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares. Cell Rep. 2017;18(9):2077\u201387.","journal-title":"Cell Rep"},{"issue":"6","key":"922_CR27","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.39107","volume":"67","author":"AT Vieira","year":"2015","unstructured":"Vieira AT, Macia L, Galv\u00e3o I, Martins FS, Canesso MC, Amaral FA, Garcia CC, et al. A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout. Arthritis Rheumatol. 2015;67(6):1646\u201356.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"922_CR28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.amjmed.2013.12.019","volume":"127","author":"T Neogi","year":"2014","unstructured":"Neogi T, Chen C, Niu J, Chaisson C, Hunter DJ, Zhang Y. Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study. Am J Med. 2014;127(4):311\u20138.","journal-title":"Am J Med"},{"issue":"9","key":"922_CR29","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/annrheumdis-2011-201215","volume":"71","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Chen C, Choi H, Chaisson C, Hunter D, Niu J, Neogi T. Purine-rich foods intake and recurrent gout attacks. Ann Rheum Dis. 2012;71(9):1448\u201353.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"922_CR30","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.4238\/2014.August.28.2","volume":"13","author":"RC Wang","year":"2014","unstructured":"Wang RC, Jiang DM. PPAR-\u03b3 agonist pioglitazone affects rat gouty arthritis by regulating cytokines. Genet Mol Res. 2014;13(3):6577\u201381.","journal-title":"Genet Mol Res"},{"issue":"1","key":"922_CR31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.10709","volume":"48","author":"T Akahoshi","year":"2003","unstructured":"Akahoshi T, Namai R, Murakami Y, Watanabe M, Matsui T, Nishimura A, Kitasato H, et al. Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals. Arthritis Rheum. 2003;48(1):231\u20139.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"922_CR32","first-page":"457","volume":"56","author":"WC Chang","year":"2017","unstructured":"Chang WC, Jan Wu YJ, Chung WH, Lee YS, Chin SW, Chen TJ, Chang YS, et al. Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis. Rheumatology (Oxford). 2017;56(3):457\u201366.","journal-title":"Rheumatology (Oxford)"},{"key":"922_CR33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s13075-015-0802-3","volume":"17","author":"C McKinney","year":"2015","unstructured":"McKinney C, Stamp LK, Dalbeth N, Topless RK, Day RO, Kannangara DR, Williams KM, et al. Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout. Arthritis Res Ther. 2015;17:288.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"922_CR34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147939","volume":"11","author":"H Rasheed","year":"2016","unstructured":"Rasheed H, McKinney C, Stamp LK, Dalbeth N, Topless RK, Day R, Kannangara D, et al. The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets. PLoS One. 2016;11(1), e0147939.","journal-title":"PLoS One"},{"issue":"3","key":"922_CR35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/annrheumdis-2014-206258","volume":"75","author":"MC Cleophas","year":"2016","unstructured":"Cleophas MC, Cri\u015fan TO, Lemmers H, Toenhake-Dijkstra H, Fossati G, Jansen TL, Dinarello CA, et al. Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases. Ann Rheum Dis. 2016;75(3):593\u2013600.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"922_CR36","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1186\/ar4531","volume":"16","author":"HM Jin","year":"2014","unstructured":"Jin HM, Kim TJ, Choi JH, Kim MJ, Cho YN, Nam KI, Kee SJ, et al. MicroRNA-155 as a proinflammatory regulator via SHIP-1 down-regulation in acute gouty arthritis. Arthritis Res Ther. 2014;16(2):R88.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"922_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbspin.2012.08.012","volume":"80","author":"E Pascual","year":"2013","unstructured":"Pascual E, Mart\u00ednez A, Ord\u00f3\u00f1ez S. Gout: the mechanism of urate crystal nucleation and growth. A hypothesis based in facts. Joint Bone Spine. 2013;80(1):1\u20134.","journal-title":"Joint Bone Spine"},{"issue":"21","key":"922_CR38","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1073\/pnas.1620910114","volume":"114","author":"TO Cri\u015fan","year":"2017","unstructured":"Cri\u015fan TO, Cleophas MCP, Novakovic B, Erler K, van de Veerdonk FL, Stunnenberg HG, Netea MG, et al. Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway. Proc Natl Acad Sci U S A. 2017;114(21):5485\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"922_CR39","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/annrheumdis-2014-206564","volume":"75","author":"TO Cri\u0219an","year":"2016","unstructured":"Cri\u0219an TO, Cleophas MC, Oosting M, Lemmers H, Toenhake-Dijkstra H, Netea MG, Jansen TL, et al. Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra. Ann Rheum Dis. 2016;75(4):755\u201362.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"922_CR40","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/rheumatology\/kes326","volume":"52","author":"R Grainger","year":"2013","unstructured":"Grainger R, McLaughlin RJ, Harrison AA, Harper JL. Hyperuricaemia elevates circulating CCL2 levels and primes monocyte trafficking in subjects with inter-critical gout. Rheumatology (Oxford). 2013;52(6):1018\u201321.","journal-title":"Rheumatology (Oxford)"},{"key":"922_CR41","doi-asserted-by":"crossref","first-page":"39884","DOI":"10.1038\/srep39884","volume":"7","author":"TT Braga","year":"2017","unstructured":"Braga TT, Forni MF, Correa-Costa M, Ramos RN, Barbuto JA, Branco P, Castoldi A, et al. Soluble uric acid activates the NLRP3 inflammasome. Sci Rep. 2017;7:39884.","journal-title":"Sci Rep."},{"issue":"1","key":"922_CR42","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1038\/s41598-017-02640-0","volume":"7","author":"JH Lai","year":"2017","unstructured":"Lai JH, Luo SF, Hung LF, Huang CY, Lien SB, Lin LC, Liu FC, et al. Physiological concentrations of soluble uric acid are chondroprotective and anti-inflammatory. Sci Rep. 2017;7(1):2359.","journal-title":"Sci Rep"},{"key":"922_CR43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ebiom.2017.04.013","volume":"21","author":"JL Kirkland","year":"2017","unstructured":"Kirkland JL, Tchkonia T. Cellular senescence: a translational perspective. EBioMedicine. 2017;21:21\u20138.","journal-title":"EBioMedicine"},{"issue":"7","key":"922_CR44","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/annrheumdis-2016-210538","volume":"76","author":"N Vazirpanah","year":"2017","unstructured":"Vazirpanah N, Kienhorst LB, Van Lochem E, Wichers C, Rossato M, Shiels PG, Dalbeth N, et al. Patients with gout have short telomeres compared with healthy participants: association of telomere length with flare frequency and cardiovascular disease in gout. Ann Rheum Dis. 2017;76(7):1313\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"922_CR45","volume":"48","author":"SM Jeon","year":"2016","unstructured":"Jeon SM. Regulation and function of AMPK in physiology and diseases. Exp Mol Med. 2016;48(7), e245.","journal-title":"Exp Mol Med"},{"issue":"7432","key":"922_CR46","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature11862","volume":"493","author":"LA O'Neill","year":"2013","unstructured":"O'Neill LA, Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature. 2013;493(7432):346\u201355.","journal-title":"Nature"},{"issue":"1","key":"922_CR47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/annrheumdis-2014-206074","volume":"75","author":"Y Wang","year":"2016","unstructured":"Wang Y, Viollet B, Terkeltaub R, Liu-Bryan R. AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages. Ann Rheum Dis. 2016;75(1):286\u201394.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"922_CR48","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00125-017-4211-9","volume":"60","author":"E B\u00f6rgeson","year":"2017","unstructured":"B\u00f6rgeson E, Wallenius V, Syed GH, Darshi M, Lantero Rodriguez J, Bi\u00f6rserud C, Ragnmark Ek M, et al. AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin. Diabetologia. 2017;60(4):729\u201339.","journal-title":"Diabetologia"},{"issue":"4","key":"922_CR49","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/annrheumdis-2015-208767","volume":"75","author":"A Abhishek","year":"2016","unstructured":"Abhishek A, Valdes AM, Doherty M. Low omega-3 fatty acid levels associate with frequent gout attacks: a case control study. Ann Rheum Dis. 2016;75(4):784\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"922_CR50","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","volume":"38","author":"Y Yan","year":"2013","unstructured":"Yan Y, Jiang W, Spinetti T, Tardivel A, Castillo R, Bourquin C, Guarda G, et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity. 2013;38(6):1154\u201363.","journal-title":"Immunity"},{"issue":"7","key":"922_CR51","doi-asserted-by":"crossref","first-page":"660","DOI":"10.5551\/jat.RV17006","volume":"24","author":"H Ohira","year":"2017","unstructured":"Ohira H, Tsutsui W, Fujioka Y. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis? J Atheroscler Thromb. 2017;24(7):660\u2013672.","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"922_CR52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1189\/jlb.3A1015-453RRR","volume":"101","author":"AT Vieira","year":"2017","unstructured":"Vieira AT, Galv\u00e3o I, Macia LM, Sernaglia \u00c9M, Vinolo MA, Garcia CC, Tavares LP, et al. Dietary fiber and the short-chain fatty acid acetate promote resolution of neutrophilic inflammation in a model of gout in mice. J Leukoc Biol. 2017;101(1):275\u201384.","journal-title":"J Leukoc Biol"},{"key":"922_CR53","doi-asserted-by":"crossref","first-page":"20602","DOI":"10.1038\/srep20602","volume":"6","author":"Z Guo","year":"2016","unstructured":"Guo Z, Zhang J, Wang Z, Ang KY, Huang S, Hou Q, Su X, et al. Intestinal microbiota distinguish gout patients from healthy humans. Sci Rep. 2016;6:20602.","journal-title":"Sci Rep"},{"key":"922_CR54","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fmicb.2017.00268","volume":"8","author":"T Shao","year":"2017","unstructured":"Shao T, Shao L, Li H, Xie Z, He Z, Wen C. Combined signature of the fecal microbiome and metabolome in patients with gout. Front Microbiol. 2017;8:268.","journal-title":"Front Microbiol"},{"issue":"1","key":"922_CR55","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13075-016-1167-y","volume":"18","author":"L Liu","year":"2016","unstructured":"Liu L, Xue Y, Zhu Y, Xuan D, Yang X, Liang M, Wang J, et al. Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout. Arthritis Res Ther. 2016;18(1):268.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"922_CR56","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s10067-015-3109-5","volume":"35","author":"M Zeng","year":"2016","unstructured":"Zeng M, Dang W, Chen B, Qing Y, Xie W, Zhao M, Zhou J. IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response. Clin Rheumatol. 2016;35(9):2251\u20138.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"922_CR57","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/annrheumdis-2014-206966","volume":"75","author":"LA Joosten","year":"2016","unstructured":"Joosten LA, Cri\u015fan TO, Azam T, Cleophas MC, Koenders MI, van de Veerdonk FL, Netea MG, et al. Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1\u03b2 and by the induction of endogenous IL-1Ra. Ann Rheum Dis. 2016;75(6):1219\u201327.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"922_CR58","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.cell.2016.10.017","volume":"167","author":"Y Li","year":"2016","unstructured":"Li Y, Oosting M, Smeekens SP, Jaeger M, Aguirre-Gamboa R, Le KT, Deelen P, et al. A functional genomics approach to understand variation in cytokine production in humans. Cell. 2016;167(4):1099\u2013110.e14.","journal-title":"Cell"},{"issue":"7252","key":"922_CR59","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature08100","volume":"460","author":"G Guarda","year":"2009","unstructured":"Guarda G, Dostert C, Staehli F, Cabalzar K, Castillo R, Tardivel A, Schneider P, et al. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature. 2009;460(7252):269\u201373.","journal-title":"Nature"},{"issue":"2","key":"922_CR60","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.immuni.2011.02.006","volume":"34","author":"G Guarda","year":"2011","unstructured":"Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, F\u00f6rster I, Farlik M, et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity. 2011;34(2):213\u201323.","journal-title":"Immunity"},{"issue":"5","key":"922_CR61","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/art.27356","volume":"62","author":"N Dalbeth","year":"2010","unstructured":"Dalbeth N, Pool B, Gamble GD, Smith T, Callon KE, McQueen FM, Cornish J. Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum. 2010;62(5):1549\u201356.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"922_CR62","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","volume":"20","author":"C Schauer","year":"2014","unstructured":"Schauer C, Janko C, Munoz LE, Zhao Y, Kienh\u00f6fer D, Frey B, Lell M, Manger B, et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med. 2014;20(5):511\u20137.","journal-title":"Nat Med"},{"issue":"3","key":"922_CR63","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/eji.201646551","volume":"47","author":"I Galv\u00e3o","year":"2017","unstructured":"Galv\u00e3o I, Vago JP, Barroso LC, Tavares LP, Queiroz-Junior CM, Costa VV, Carneiro FS, et al. Annexin A1 promotes timely resolution of inflammation in murine gout. Eur J Immunol. 2017;47(3):585\u201396.","journal-title":"Eur J Immunol"},{"issue":"1","key":"922_CR64","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/BOR.0000000000000357","volume":"29","author":"YL Lightfoot","year":"2017","unstructured":"Lightfoot YL, Kaplan MJ. Disentangling the role of neutrophil extracellular traps in rheumatic diseases. Curr Opin Rheumatol. 2017;29(1):65\u201370.","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"922_CR65","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1002\/art.22137","volume":"54","author":"DM Rose","year":"2006","unstructured":"Rose DM, Sydlaske AD, Agha-Babakhani A, Johnson K, Terkeltaub R. Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils. Arthritis Rheum. 2006;54(10):3363\u201371.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"922_CR66","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.immuni.2013.12.015","volume":"40","author":"K Neumann","year":"2014","unstructured":"Neumann K, Casti\u00f1eiras-Vilari\u00f1o M, H\u00f6ckendorf U, Hannesschl\u00e4ger N, Lemeer S, Kupka D, Meyermann S, et al. Clec12a is an inhibitory receptor for uric acid crystals that regulates inflammation in response to cell death. Immunity. 2014;40(3):389\u201399.","journal-title":"Immunity"},{"issue":"4","key":"922_CR67","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/annrheumdis-2014-205409","volume":"74","author":"N Dalbeth","year":"2015","unstructured":"Dalbeth N, Pool B, Shaw OM, Harper JL, Tan P, Franklin C, House ME, et al. Role of miR-146a in regulation of the acute inflammatory response to monosodium urate crystals. Ann Rheum Dis. 2015;74(4):786\u201390.","journal-title":"Ann Rheum Dis"},{"key":"922_CR68","volume":"13","author":"AC Puhl","year":"2015","unstructured":"Puhl AC, Milton FA, Cvoro A, Sieglaff DH, Campos JC, Bernardes A, Filgueira CS, et al. Mechanisms of peroxisome proliferator activated receptor \u03b3 regulation by non-steroidal anti-inflammatory drugs. Nucl Recept Signal. 2015;13, e004.","journal-title":"Nucl Recept Signal"},{"issue":"2","key":"922_CR69","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1189\/jlb.0312128","volume":"92","author":"M Perretti","year":"2012","unstructured":"Perretti M. Editorial: to resolve or not to resolve: annexin A1 pushes resolution on track. J Leukoc Biol. 2012;92(2):245\u20137.","journal-title":"J Leukoc Biol"},{"issue":"44","key":"922_CR70","doi-asserted-by":"crossref","first-page":"38703","DOI":"10.1074\/jbc.M111.275370","volume":"286","author":"JM Busillo","year":"2011","unstructured":"Busillo JM, Azzam KM, Cidlowski JA. Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome. J Biol Chem. 2011;286(44):38703\u201313.","journal-title":"J Biol Chem"},{"issue":"11","key":"922_CR71","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","volume":"71","author":"N Schlesinger","year":"2012","unstructured":"Schlesinger N, Alten RE, Bardin T, Schumacher HR, Bloch M, Gimona A, Krammer G, et al. Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Ann Rheum Dis. 2012;71(11):1839\u201348.","journal-title":"Ann Rheum Dis"},{"key":"922_CR72","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000524","author":"SE Petite","year":"2016","unstructured":"Petite SE. Effectiveness of anakinra in acute gout: a retrospective review of initial and refractory therapy. Am J Ther. 2016. doi:\n10.1097\/MJT.0000000000000524\n\n.","journal-title":"Am J Ther"},{"issue":"1","key":"922_CR73","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/ar4159","volume":"15","author":"RA Terkeltaub","year":"2013","unstructured":"Terkeltaub RA, Schumacher HR, Carter JD, Baraf HS, Evans RR, Wang J, King-Davis S, et al. Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator. Arthritis Res Ther. 2013;15(1):R25.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"922_CR74","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/art.39684","volume":"68","author":"J Poiley","year":"2016","unstructured":"Poiley J, Steinberg AS, Choi YJ, Davis CS, Martin RL, McWherter CA, Boudes PF, et al. A randomized, double-blind, active- and placebo-controlled efficacy and safety study of arhalofenate for reducing flare in patients with gout. Arthritis Rheumatol. 2016;68(8):2027\u201334.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"922_CR75","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1002\/art.39318","volume":"67","author":"LB Kienhorst","year":"2015","unstructured":"Kienhorst LB, van Lochem E, Kievit W, Dalbeth N, Merriman ME, Phipps-Green A, Loof A, et al. Gout is a chronic inflammatory disease in which high levels of interleukin-8 (CXCL8), myeloid-related protein 8\/myeloid-related protein 14 complex, and an altered proteome are associated with diabetes mellitus and cardiovascular disease. Arthritis Rheumatol. 2015;67(12):3303\u201313.","journal-title":"Arthritis Rheumatol"},{"key":"922_CR76","doi-asserted-by":"crossref","first-page":"38622","DOI":"10.1038\/srep38622","volume":"6","author":"HE Lee","year":"2016","unstructured":"Lee HE, Yang G, Kim ND, Jeong S, Jung Y, Choi JY, Park HH, et al. Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout. Sci Rep. 2016;6:38622.","journal-title":"Sci Rep"},{"issue":"4","key":"922_CR77","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1096\/fj.201601222R","volume":"31","author":"CN Serhan","year":"2017","unstructured":"Serhan CN. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. FASEB J. 2017;31(4):1273\u201388.","journal-title":"FASEB J"},{"key":"922_CR78","first-page":"129","volume":"10","author":"MC Cleophas","year":"2017","unstructured":"Cleophas MC, Joosten LA, Stamp LK, Dalbeth N, Woodward OM, Merriman TR. ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches. Pharmgenomics Pers Med. 2017;10:129\u201342.","journal-title":"Pharmgenomics Pers Med"},{"issue":"2","key":"922_CR79","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/art.38917","volume":"67","author":"HK Choi","year":"2015","unstructured":"Choi HK, Niu J, Neogi T, Chen CA, Chaisson C, Hunter D, Zhang Y. Nocturnal risk of gout attacks. Arthritis Rheumatol. 2015;67(2):555\u201362.","journal-title":"Arthritis Rheumatol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-017-0922-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T07:49:28Z","timestamp":1502437768000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-017-0922-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,18]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["922"],"URL":"https:\/\/doi.org\/10.1186\/s12916-017-0922-5","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,18]]},"article-number":"158"}}